Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024
Vir Biotechnology (Nasdaq: VIR) has announced that it will provide a corporate update and report its third quarter 2024 financial results on October 31, 2024. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day. The financial results and corporate update will be released via a press release after market close and will be accessible on the company's website. Interested parties can join the conference call through a webcast or by dialing in. A recorded version of the call will be available on the website approximately two hours after the event and will be archived for 30 days.
Vir Biotechnology (Nasdaq: VIR) ha annunciato che fornirà un aggiornamento aziendale e riporterà i suoi risultati finanziari del terzo trimestre 2024 il 31 ottobre 2024. L'azienda terrà una teleconferenza alle 1:30 p.m. ora del Pacifico / 4:30 p.m. ora dell'Est lo stesso giorno. I risultati finanziari e l'aggiornamento aziendale saranno comunicati tramite un comunicato stampa dopo la chiusura del mercato e saranno accessibili sul sito web dell'azienda. Le parti interessate possono partecipare alla teleconferenza tramite un webcast o componendo il numero. Una versione registrata della chiamata sarà disponibile sul sito web circa due ore dopo l'evento e sarà archiviata per 30 giorni.
Vir Biotechnology (Nasdaq: VIR) ha anunciado que proporcionará una actualización corporativa e informará sobre sus resultados financieros del tercer trimestre de 2024 el 31 de octubre de 2024. La compañía llevará a cabo una conferencia telefónica a las 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este el mismo día. Los resultados financieros y la actualización corporativa se publicarán mediante un comunicado de prensa después del cierre del mercado y serán accesibles en el sitio web de la empresa. Las partes interesadas pueden unirse a la conferencia telefónica a través de un webcast o llamando por teléfono. Una versión grabada de la llamada estará disponible en el sitio web aproximadamente dos horas después del evento y se archivará durante 30 días.
Vir Biotechnology (Nasdaq: VIR)는 2024년 3분기 재무 결과를 2024년 10월 31일에 발표하고 기업 업데이트를 제공할 것이라고 발표했습니다. 회사는 같은 날 태평양 표준시 오후 1시 30분 / 동부 표준시 오후 4시 30분에 전화 회의 를 개최할 예정입니다. 재무 결과와 기업 업데이트는 장 마감 후 보도 자료를 통해 발표되며, 회사 웹사이트에서 확인할 수 있습니다. 관심 있는 분들은 웹캐스트를 통해 회의에 참여하거나 전화를 통해 참여할 수 있습니다. 통화의 녹음된 버전은 이벤트 후 약 두 시간 동안 웹사이트에서 제공되며 30일 동안 보관됩니다.
Vir Biotechnology (Nasdaq: VIR) a annoncé qu'il fournira une mise à jour de l'entreprise et fera rapport sur ses résultats financiers du troisième trimestre 2024 le 31 octobre 2024. L'entreprise animera une conférence téléphonique le même jour à 13h30, heure du Pacifique / 16h30, heure de l'Est. Les résultats financiers et la mise à jour de l'entreprise seront publiés par un communiqué de presse après la clôture du marché et seront accessibles sur le site web de l'entreprise. Les parties intéressées peuvent participer à la conférence téléphonique via un webinaire ou en appelant. Une version enregistrée de l'appel sera disponible sur le site web environ deux heures après l'événement et sera archivée pendant 30 jours.
Vir Biotechnology (Nasdaq: VIR) hat angekündigt, dass es ein Unternehmensupdate geben und seine finanziellen Ergebnisse des dritten Quartals 2024 am 31. Oktober 2024 bekannt geben wird. Das Unternehmen wird am selben Tag um 13:30 Uhr Pazifischer Zeit / 16:30 Uhr Eastern Zeit eine Telefonkonferenz veranstalten. Die finanziellen Ergebnisse und das Unternehmensupdate werden nach Marktschluss per Pressemitteilung veröffentlicht und sind auf der Unternehmenswebsite zugänglich. Interessierte Parteien können über einen Webcast oder durch Einwahl an der Telefonkonferenz teilnehmen. Eine aufgezeichnete Version des Anrufs wird ungefähr zwei Stunden nach der Veranstaltung auf der Website verfügbar sein und 30 Tage lang archiviert werden.
- None.
- None.
The corporate update and financial results will be provided via a press release after market close and will be accessible under Press Releases in the Investors section of the Vir website at www.vir.bio. Participants may access the conference call via webcast on the Events & Presentations page of Vir’s website at https://investors.vir.bio/events-presentations or listen in by dialing the
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Vir’s clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections, in addition to multiple oncology programs. Vir also has a preclinical portfolio of programs across a range of other infectious diseases and oncologic malignancies. Vir routinely posts information that may be important to investors on its website.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241017372102/en/
Media
Arran Attridge
Senior Vice President, Corporate Communications
aattridge@vir.bio
Investors
Richard Lepke
Senior Director, Investor Relations
rlepke@vir.bio
Source: Vir Biotechnology, Inc.
FAQ
When will Vir Biotechnology (VIR) report its Q3 2024 financial results?
How can investors access Vir Biotechnology's (VIR) Q3 2024 earnings call?
Where can I find Vir Biotechnology's (VIR) Q3 2024 financial results press release?
Will there be a replay available for Vir Biotechnology's (VIR) Q3 2024 earnings call?
